---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-088393"
form_type: "8-K"
ticker: "NNVC"
cik: "0001379006"
company_name: "NANOVIRICIDES, INC."
filed_at: "2026-07-30T10:02:18+00:00"
generated_at: "2026-07-30T10:10:53.263084+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NanoViricides raises ~$3.8M in registered direct offering of common stock and warrants

## Summary
- Gross proceeds of ~$3.8M from sale of 2,516,339 shares (or pre-funded warrants) and warrants to purchase 2,516,339 shares at $1.75.
- Offering closed on July 27, 2026; net proceeds for working capital, R&D, clinical trials, and strategic purposes.
- CEO and principal stockholder TheraCour Pharma entered 30-day lock-up agreements restricting share sales.
- D. Boral Capital acted as exclusive placement agent with 7.0% cash fee and up to $50,000 expense reimbursement.

## SEC filing metadata
- accession: 0001104659-26-088393
- form_type: 8-K
- ticker: NNVC
- cik: 0001379006
- company_name: NANOVIRICIDES, INC.
- filed_at: 2026-07-30T10:02:18+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/0001104659-26-088393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/tm2621493d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-088393
- JSON: https://secwatch.observer/filing/0001104659-26-088393.json
- Plain text: https://secwatch.observer/filing/0001104659-26-088393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.